XOTEN F10MG (Fenofibrate (160mg) + Rosuvastatin (10mg))

Xoten F 160mg/10mg Tablet is a medicinal formulation that combines two agents effective in reducing lipid levels in the body. This medication is indicated for individuals who have not achieved sufficient lipid reduction through lifestyle modifications alone, such as adhering to a low-fat diet. By facilitating the lowering of cholesterol and triglyceride concentrations in the bloodstream, this tablet may contribute to a decreased likelihood of developing cardiovascular conditions. The administration of Xoten F can occur either with food or on an empty stomach, allowing for flexibility in dosing. It is advisable to take the tablet consistently at the same time each day to enhance adherence to the treatment regimen. The prescribing physician will determine the appropriate dosage based on individual lipid levels and the patient’s response to the medication. Although many individuals with elevated cholesterol and triglycerides may not exhibit symptoms, discontinuing the medication can lead to an increase in lipid levels, exacerbating the condition and raising the risk of heart disease and stroke. Regular monitoring of lipid profiles is essential while undergoing treatment with this medication. It is important to recognize that Xoten F should be part of a comprehensive treatment strategy that includes dietary modifications, physical activity, cessation of smoking, controlled alcohol consumption, and weight management. While taking this medication, it is generally safe to maintain a normal diet, although it is recommended to limit intake of high-fat foods. Some common adverse effects may include nausea, abdominal discomfort, constipation, headaches, excessive gas, and muscle ache. These effects are typically mild and tend to resolve with time. However, if symptoms persist or if there are signs such as jaundice, unusual bleeding or bruising, or severe unexplained muscle pain, medical consultation is necessary. Periodic liver function assessments may also be suggested while on this treatment. This medication is contraindicated in individuals with liver disorders. Prior to starting treatment, patients should inform their physician of any kidney issues and should also disclose if they are pregnant, planning to conceive, or currently nursing. Diabetic patients should keep track of their blood glucose levels, as this medication may elevate them.